LianBio
Latest round
- Angel
Last raised
- Dec 2019
Total raised
- Undisclosed
Investors
- 1
About LianBio
Based in Shanghai, China, and founded in 2019 by CEO and founder Yizhe Wang, LianBio operates as a pharmaceutical company that provides research and development of new drugs for the treatment of cardiology and oncology., Sphera Funds Management, T. LianBio offers cardiology, pulmonary medicine, ophthalmology, and inflammatory disorders medicine. In addition, the company develops mavacamten for treating obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction. LianBio also develops other treatments, including TP-03, NBTXR3, Infigratinib, BBP-398, Omilancor, NH-13, LYR-210 and Sisunatovir. TP-03 is used for the treatment of Demodex blepharitis while NBTXR3 is used for the treatment of neck and head squamous cell carcinoma, and solid tumor IO combinations. In addition, Infigratinib is used for the treatment of first- and second-line cholangiocarcinoma and gastric while BBP-398 is used for the treatment of solid tumors. NH-13 is used for the treatment of ulcerative colitis, Omnilancor for treatment of Crohn's and ulcerative diseases, Sisunatovir for the treatment of respiratory syncytial virus and LYR-210 for chronic rhinosinusitis.
Who invested in LianBio
1 investor across 1 round
See all investors in LianBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Dec 1, 2019
Amount
Undisclosed
Investors
Questions about LianBio
Who invested in LianBio?
LianBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LianBio raised?
LianBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did LianBio last raise money?
LianBio's most recent round on record is a Angel, in Dec 2019.
What does LianBio do?
Based in Shanghai, China, and founded in 2019 by CEO and founder Yizhe Wang, LianBio operates as a pharmaceutical company that provides research and development of new drugs for the treatment of cardiology and oncology.
Where is LianBio headquartered?
LianBio is headquartered in Shanghai, China.
Which VCs invest in companies like LianBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at LianBio's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like LianBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.